2 added 8 characters in body
source | link

Let's add and rebold a few more words to understand the context:

Deal #1 -Novartis and GlaxoSmithKline, two of the world's top drugmakers, have struck a multi-billion-dollar deal to join forces and reshape their businesses.The deal involves swapping assets and combining their consumer health units. Novartis will acquire GSK's cancer drugs business for 16bn dollars (£9.5bn) and sell its vaccines division, excluding the flu unit, to GSK for 7.1bn dollars.

Deal #2 -In a separate deal, Novartis has agreed to sell its animal health division to Lilly for nearly $5.4bn.Novartis said the moves would help the firm focus on its key businesses. (The keybusiness of Novartis is to deal with human health)

"The transactions [Deal #1 and #2] mark a transformational moment for Novartis," Joseph Jimenez, chief executive of Novartis, said in a statement."They (referring to the transactions of two deals) also improve our financial strength, and are expected to add to our growth rates (company shall grow faster) and margins (overall profit from the sales) immediately."

Let's rebold a few more words to understand the context:

Deal #1 -Novartis and GlaxoSmithKline, two of the world's top drugmakers, have struck a multi-billion-dollar deal to join forces and reshape their businesses.The deal involves swapping assets and combining their consumer health units. Novartis will acquire GSK's cancer drugs business for 16bn dollars (£9.5bn) and sell its vaccines division, excluding the flu unit, to GSK for 7.1bn dollars.

Deal #2 -In a separate deal, Novartis has agreed to sell its animal health division to Lilly for nearly $5.4bn.Novartis said the moves would help the firm focus on its key businesses. (The keybusiness of Novartis is to deal with human health)

"The transactions [Deal #1 and #2] mark a transformational moment for Novartis," Joseph Jimenez, chief executive of Novartis, said in a statement."They (referring to the transactions of two deals) also improve our financial strength, and are expected to add to our growth rates (company shall grow faster) and margins (overall profit from the sales) immediately."

Let's add and rebold a few more words to understand the context:

Deal #1 -Novartis and GlaxoSmithKline, two of the world's top drugmakers, have struck a multi-billion-dollar deal to join forces and reshape their businesses.The deal involves swapping assets and combining their consumer health units. Novartis will acquire GSK's cancer drugs business for 16bn dollars (£9.5bn) and sell its vaccines division, excluding the flu unit, to GSK for 7.1bn dollars.

Deal #2 -In a separate deal, Novartis has agreed to sell its animal health division to Lilly for nearly $5.4bn.Novartis said the moves would help the firm focus on its key businesses. (The keybusiness of Novartis is to deal with human health)

"The transactions [Deal #1 and #2] mark a transformational moment for Novartis," Joseph Jimenez, chief executive of Novartis, said in a statement."They (referring to the transactions of two deals) also improve our financial strength, and are expected to add to our growth rates (company shall grow faster) and margins (overall profit from the sales) immediately."

1
source | link

Let's rebold a few more words to understand the context:

Deal #1 -Novartis and GlaxoSmithKline, two of the world's top drugmakers, have struck a multi-billion-dollar deal to join forces and reshape their businesses.The deal involves swapping assets and combining their consumer health units. Novartis will acquire GSK's cancer drugs business for 16bn dollars (£9.5bn) and sell its vaccines division, excluding the flu unit, to GSK for 7.1bn dollars.

Deal #2 -In a separate deal, Novartis has agreed to sell its animal health division to Lilly for nearly $5.4bn.Novartis said the moves would help the firm focus on its key businesses. (The keybusiness of Novartis is to deal with human health)

"The transactions [Deal #1 and #2] mark a transformational moment for Novartis," Joseph Jimenez, chief executive of Novartis, said in a statement."They (referring to the transactions of two deals) also improve our financial strength, and are expected to add to our growth rates (company shall grow faster) and margins (overall profit from the sales) immediately."